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GDNF in a Bind Minireview
with Known Orphan:
Accessory Implicated in New Twist
Ronald M. Lindsay and George D. Yancopoulos a series of recent papers, analysis of mice bearing null
mutations in GDNF have led to a number of quite unex-Regeneron Pharmaceuticals, Incorporated
pected surprises, indicating that the primary role of777 Old Saw Mill River Road
GDNF in vivo may lie outside the nervous system (Sa´n-Tarrytown, New York 10591
chez et al., 1996; Pichel et al., 1996; Moore et al., 1996).
At birth, GDNF2/2 mice have no apparent deficit in their
complement of dopaminergic neurons, and only minor
GDNF: A Treatment for Parkinson’s Disease? losses of spinal motor neurons. Thus, the postulated
Not long after success with ciliary neurotrophic factor role of GDNF as a developmentally important target-
(CNTF; Lin et al., 1989), Leu-Fen Lin and Frank Collins derived neurotrophic factor for nigral dopaminergic neu-
repeated the arduous task of characterizing a novel neu- rons and/or spinal or facial motor neurons would now
rotrophic factor through protein purification and se- seem to be in question. Although substantial deficits
quencing. In doing so, they thought they had discovered in cranial sensory neurons (z40% loss in the nodose/
a new transforming growth factor b (TGFb)-like growth petrosal complex), sympathetic neurons (z35% loss in
factor that was an extraordinarily specific and remark- the superior cervical ganglion), and enteric neurons are
ably potent target-derived neurotrophic factor for dopa- indeed evident in GDNF2/2 mice, the most prominent
minergic neurons (Lin et al., 1993). Follow-up work on and surprising phenotype of such null mutants is the
the distribution of this factor, glial-derived neurotrophic complete absence of kidney tissue. Although surprising
factor (GDNF), provided supportive evidence that this to the neurotrophic factor fraternity, the marked similar-
molecule was in the right place at the right time to play ity in phenotype between GDNF null mutant mice and
a crucial role in the genesis of the nigrostriatal dopamin- an earlier knockout of the orphan receptor tyrosine ki-
ergic pathway (Poulsen et al., 1994). Additionally, animal nase c-Ret (Ret) was cause for simultaneous illumination
efficacy studies demonstrated protective effects of ex- of more than a few light bulbs.
ogenousGDNF invarious models of Parkinson’s disease On primary and secondary structural characteristics,
(reviewed by Lindsay, 1995). As is often the case, how- GDNF was initially classified as a distant member of the
TGFb family. As such, the putative receptor for GDNFever, this initially simple picture has become much more
was expected to be a serine/threonine receptor tyrosinecomplex, both in terms of biology and receptor
kinase. The striking similarity in the phenotype ofstructure.
GDNF2/2 and Ret2/2 mice, however, suggested a quiteNot Just a Dopaminergic Factor
different possibility: involvement of Ret in GDNF signal-GDNF now appears to have pharmacological, if not
ing. As evident from a flurry of recent papers, not onlyphysiological, actions on a wide variety of neurons and
is Ret no longer an orphanreceptor, but a Ret-containingjoins the ranks of a number of polypeptide growth fac-
GDNF receptor complex appears to be a member of ators that can maintain the survival of motor neurons in
newly emerging class of receptor tyrosine kinases thatcell culture and prevent death of these cells in vivo
require accessory components, more analogous to cy-following axotomy (Henderson et al., 1994). In keeping
tokine receptors such as the CNTF receptor complex.with a possible classic target-derived role, GDNF is
GDNFR-a: The First Componentpresent in muscle and is also expressed in peripheral
of the GDNF Receptornerve (Henderson et al., 1994; Trupp et al., 1995). As
Starting from first principles, two different groups (Jingthe range of GDNF-responsive cells has further broad-
et al., 1996; Treanor et al., 1996) set out to clone a GDNFened to include several classes of peripheral neurons
receptor by utilizing an expression cloning strategy.(Buj-Bello et al., 1995; Trupp et al., 1995), the case for
Both groups cloned cDNAs encoding the same GDNF-GDNF playing a target-derived role in the periphery
binding protein, but identification of this protein raised
seems not to be confined to motor neurons. Thus, in
more questions than it answered. The GDNF-binding
terms of its neuronal specificity and tissue distribution,
protein, termed GDNFR-a, was not related to any known
GDNF would appear to be as broadly acting and as protein and was found to be anchored to the cell surface
widely expressed as other neurotrophic factors such as via a glycosylphosphatidylinositol (GPI) linkage, thus
CNTF or brain-derived neurotrophic factor (BDNF). lacking a cytoplasmic domain. The absence of a cyto-
Illuminating Knockouts: A Neurotrophic plasmic domain suggested that if GDNFR-a were part
or Urotrophic Factor? of functional receptor for GDNF, it would needto interact
As the discovery of polypeptide growth factors with with a signaling partner. Treanor and colleagues pro-
actions on neurons has increased, so has the difficulty vided compelling evidence that GDNFR-a was indeed
in strictly categorizing such molecules as primarily neu- part of a functional receptor for GDNF. Not only was
rotrophic factors. This stems from the fact that many GDNFR-a expressed on all known neuronal targets of
factors that are trophic for neurons also have a variety GDNF action, but treatment of such neuronal targets
of effects on multiple classes of non-neuronal cells. Per- with a phospholipase (PIPLC) that should release GPI-
haps an acid test, that so far only nerve growth factor linked proteins such as GDNFR-a reduced the GDNF-
(NGF) and related neurotrophins have passed with dis- responsiveness of these targets. Most convincingly, ad-
tinction, is clear demonstration of a predominantly neu- dition of high concentrations of soluble GDNFR-a to
ronal phenotype in transgenic mice bearing null muta- neurons treated with PIPLC restored their ability to re-
spond to GDNF.tions of the growth factor in question. As published in
Neuron
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So for Jing et al. and Treanor et al., the search was not only did Durbec et al. find that explants from Ret-
deficient embryos did not respond to GDNF, but theyon for a second component of the GDNF receptor. Their
developing stories already indicated that GDNF might showed that expression of Ret in Xenopus embryos
made them responsive to GDNF. Similarly, Trupp et al.utilize a receptor quite different from other TGFb family
members; although TGFbs can bind to accessory mem- demonstrated that ectopic expression of Ret in 3T3 fi-
broblasts conferred GDNF responsiveness. Durbec etbrane proteins such as beta-glycan in addition to their
serine/threonine kinase receptors, GDNFR-a was not al. and Trupp et al. also demonstrated that, when ectopi-
callyexpressed in their respective systems, Retcould bevery reminiscent of beta-glycan. In fact, GDNFR-a was
most reminiscent of CNTFRa, the first component of a inducibly tyrosine phosphorylated by GDNF and could
directly bind to GDNF.three-component receptor system for a neurotrophic
cytokine, CNTF (Davis et al., 1991). GDNFR-a displays Whereas Durbec et al. and Trupp et al. found no evi-
dence for GDNF binding in the absence of Ret, andno sequence homology to CNTFRa and lacks the struc-
tural features characteristic of CNTFRa and other cyto- suggested that Ret was absolutely necessary for GDNF
binding in their systems, the two other groups exploringkine receptors. However, CNTFRa was the only other
growth factor receptor known to be GPI linked. Further- the GDNF receptor system came to a much different
conclusion. Jing et al. and Treanor et al. had identifiedmore, it was known that CNTFRa does not play any
direct role in signaling, but instead served to bind to GDNFR-a based on its ability to bind GDNF in the ab-
sence of Ret, and they went on to show that GDNFR-aCNTF and allow it to then bind and activate the two b
signaling components of its receptor, gp130 and LIFRb was required for Ret to bind and be activated by GDNF.
Both the latter groups also convincingly demonstrated(Davis et al., 1993b); like GDNFR-a, CNTFRa could be
supplied in either membrane-bound or soluble form that, after GDNF binding, GDNFR-a and Ret could be
isolated in the same complex.(Davis et al., 1993a). If GDNF used a receptor complex
analogous to the system used by CNTF, although it was Can the results of the two groups that found that
GDNFR-a is required be reconciled with those of theclear that the details must be substantially different.
Since GDNFR-a was not structurally related to CNTFRa, two groups that suggested that Ret might be sufficient?
It is of course possible that small amounts of GDNFR-aadditional subunits of the GDNF receptor system were
unlikely to be related to the secondary components of (or a relative) are present in some of the experiments
in which the investigators assumed they were lookingthe CNTF receptor.
Enter an Orphan Receptor Tyrosine Kinase: Ret at only Ret. Alternatively, it is worth invoking once
again the example of the CNTF receptor complex. CNTFFor Jing and colleagues and Treanor and colleagues,
the first clue concerning a potential signaling partner can indeed weakly induce responses in cells lacking
CNTFRa, but expressing both the b components (Davisfor GDNFR-a came from the realization that the renal
and enteric nervous system defects in GDNF2/2 mice et al., 1993a). However, addition of CNTFRa to these
cells can shift dose responsiveness by two to threewere strikingly reminiscent of those previously de-
scribed in mice lacking Ret. The likelihood that GDNF orders of magnitude. Similarly, a weak innate Ret re-
sponsiveness may be analogously shifted by GDNFR-a.and Ret participated in the same signaling pathway
prompted Jing et al. and Treanor et al. to pursue the Consistent with such a possibility, Trupp et al. report
that Ret, in the purported absence of GDNFR-a, canpossibility that Ret was the required signaling partner
for GDNFR-a. bind to GDNF with an affinity (Kd z275 pM) 10- to 100-
fold lower than that reported by Jing et al. and TreanorCoincidentally, two other groups were considering the
possibility that Ret might serve as a receptor for GDNF, et al. for GDNFR-a. Surprisingly, although the reported
binding of GDNF to GDNFR-a is of higher affinity thaneven although they were apparently unaware of the simi-
larity between the Ret and GDNF knockouts. Trupp et that of GDNF to Ret, the combination of GDNFR-a and
Ret does not seem to yield an even higher affinity site,al. (1996) had identified a protein in a motor neuron cell
line that could be cross-linked to GDNF and could be as might be expected (Jing et al., 1996; Treanor et al.,
1996).precipitated by antibodies to phosphotyrosine; since
this protein was about the same size as Ret (z155 kDa), Now that discrepancies in some of the details have
been defined, extensive binding and activity profilesand since Ret was known to be expressed in motor
neurons, Trupp et al. then guessed that Ret might be must be undertaken to understand precisely the innate
responsiveness of Ret as well as the strictness of theacting as a GDNF receptor. Durbec et al. (1996) simply
noticed that GDNF was most highly expressed in the requirement for GDNFR-a. First, the precise distribu-
tions of both receptor components must be explored.gut and kidney, where the most notable defects were
seen in the mice lacking Ret, and wondered whether In addition, it must be determined whether GDNF homo-
logs exist that share GDNFR-a and Ret, or converselyGDNF might work via Ret.
The GDNF Receptor Complex: Controversy whether relatives of either GDNFR-a or Ret exist and
serve as receptors for GDNF. Arguing against the latterin the Details
Following up ontheir respective hunches, all four groups possibilities, initial distribution analysis indicate that
GDNFR-a and Ret are both expressed in most knowncame to the conclusion that Ret was indeed a functional
receptor component for GDNF, although they disagreed targets of GDNF action; these distribution data, as well
as the similarity of the knockout phenotypes, addition-about the details of the receptor complex. Durbec et al.
and Trupp et al. provided direct functional data that Ret ally argue against the possibility that GDNF can also use
a totally unrelated receptor (such as one more related towas involved in mediating GDNF biological responses;
Minireview
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those used by TGFb family members) to mediate some
of its actions.
GDNF Receptor Complex: More like a Cytokine
Receptor or Other Receptor
Tyrosine Kinases?
The emerging view of the GDNF receptor complex, par-
ticularly from the Jing et al. and Treanor et al. perspec-
tive, reveals a multicomponent receptor reminiscent of
multicomponent cytokine receptors in general, and the
CNTF receptor complex in particular. In such receptor
systems, an accessory receptor subunit first binds the
ligand and presents it to the signaling components of
the receptor, which are in turn activated by their dimer-
ization (homodimerization or heterodimerization); this
dimerization activates tyrosine kinases (the Janus ki-
nases or JAKs), which arenoncovalently associated with
the cytoplasmic domains of the signaling components
(Stahl and Yancopoulos, 1993). It remains unclear as to
how the accessory component facilitates ligand binding
to, and dimerization of, the signaling components. One
possibility is that the ligand and the accessory receptor
present a combined surface for binding to the signaling
components; alternatively, the accessory component
Figure 1. Similarities in General Organization of Different Classes
may change the conformation of the ligand and thus its of Cytokine Receptors as Compared with Emerging Classes of Re-
ability to bind the signaling components. ceptor Tyrosine Kinases
Ret is not alone among receptor tyrosine kinases in For both cytokine receptors as well as receptor tyrosine kinases,
its dependence on an accessory receptor component. there are classes for which the receptor signal transducing receptor
components (R1 and R2) are activated by either homo- (R1 5 R2) orThe most extensively characterized precedent is that of
hetero- (R1≠ R2) dimerization in the absence of a required accessorythe receptors for members of the fibroblast growth fac-
(nonsignaling) receptor component. Conversely, there are classestor (FGF) family, which require heparin-containing pro-
for which an accessory (a) component is required. Note that forteoglycans to help dimerize or cluster the ligands so
receptor tyrosine kinases, the tyrosine kinase activity is intrinsic to
they can in turn aggregate and activate their receptors the signal-transducing receptor components themselves. On the
(Schlessinger et al., 1995). Similarly, Eph family ligands other hand, for the cytokine receptors, the receptor components
are noncovalently associated with cytoplasmic tyrosine kinasescannot activate their receptors when presented in solu-
(members of the JAK family) that become activated upon receptorble form, but are activated by an undefined clustering
dimerization. Also note that two a components are included in themechanism normally provided by the cell surface (Davis
final receptor complex, as has been shown for the IL-6 and CNTFet al., 1994). However, the receptor tyrosine kinase most
receptors but not yet for Ret or MuSK. It has also not been deter-
reminiscent of Ret may be the recently defined agrin mined whether Ret or MuSK homo- or heterodimerize, though it is
receptor component, known as MuSK, which is involved most likely they are activated by homodimerization. In all the cases
shown, the receptor complexes are thought to assemble from ini-in inducing all aspects of neuromuscular junction forma-
tially dissociated components in sequential fashion in response totion (DeChiara et al., 1996). To be activated by agrin,
ligand binding.MuSK requires an accessory component normally found
only on the surface of muscle cells (Glass et al., 1996).
Thus, it begins to appear that, just as there are many
components (e.g., cytokines such as CNTF or the relatedclasses of cytokine receptors (Stahl and Yancopoulos,
interleukin-6 [IL-6], and the ligands for Ret and MuSK,1993), receptor tyrosine kinases come in many flavors.
see Figure 1). In thecase of the CNTF and IL-6 accessoryIn the least complex versions of both cytokine receptors
components, recent evidence suggest that two of theand receptor tyrosine kinases, the cognate ligand acti-
accessory components are present in the final complexvates its receptor by simply inducing receptor homodi-
along with the dimerized signaling components (De Se-merization (e.g., cytokines such as growth hormone and
rio et al. 1995), raising the possibility that the same mayerythropoietin, or ligands for theepidermal growth factor
be true for GDNFR-a in its final complex. However, it[EGF] receptor tyrosine kinase; see Figure 1, top). Other
should be pointed out that the accessory componentsligands are able to activate by inducing heterodimeriza-
seem to be quite variable in their structures, functions,tion of two distinct (but closely related) receptor compo-
and mechanisms of actions. Whereas the accessorynents, both of which have signaling capabilities (e.g.,
component for the CNTF and IL-6 receptors are mem-cytokines such as the interferons or leukemia inhibitory
bers of the cytokine receptor subfamily, the accessoryfactor [LIF], and the ligands for the ErbB receptor tyro-
component for the IL-2 receptor is not and has a totallysine kinases; see Figure 1). The most complex forms of
unrelated structure as well as mechanismof action. Sim-cytokine receptors as well as receptor tyrosine kinases
ilarly diverse are the accessory components used byrequire the ligand to bind to an accessory receptor com-
Ret and FGF receptors, as well as poorly understoodponent, which lacks signaling capability, before it in-
duces either homo- or heterodimerization of its signaling potential accessory components such as the p75LNGFR
Neuron
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Durbec, P., Marcos, C.V., Wartiowaara, K., Suvanto, P., Smith, D.,component shared by the NGF family of neurotrophic
Ponder, B., Constantini, F., Saarma, M., Sariola, H., and Pachnis, V.factors.
(1996). Nature 381, 789–793.Why Bother with an Accessory Component
Glass, D.J., Bowen, D.C., Stitt, T.N., Radziejewski, C., Bruno, J.,for Ret?
Ryan, T.E., Gies, D.R., Shah, S., Mattson, K., Burden, S.J., DiStefano,
In the case of the CNTF family of factors, it is clear P.S., Valenzuela, D.M., DeChiara, T.M., and Yancopoulos, G.D.
that accessory receptor components are economical, (1996). Cell 85, 513–524.
as they allow multiple factors to share the same signal- Henderson, C.E.,Phillips, H.S., Pollock, R.A., Davies, A.M., Lemeulle,
transducing receptor subunits (Stahl and Yancopoulos, C., Armanini, M., Simpson, L.C., Moffet, B., Vandlen, R.A., Koliatsos,
V.E., and Rosenthal, A. (1994). Science 266, 1062–1064.1993). If Ret is not found to be shared by other ligands
using their own specificity-conferring a components, Jing, S., Wen, D., Yu, Y., Holst, P.L., Luo, Y., Fang, M., Tamir, R.,
Antonio, L., Hu, Z., Cupples, R., Louis, J.-C., Hu, S., Altrock, B.W.,why has nature created this extra degree of complexity
and Fox, G.M. (1996). Cell 85, 1113–1124.for a receptor tyrosine kinase? A possible explanation
Lin, L.-F.H., Mismer, D., Lile, J.D., Armes, L., Butler, E.T., III, Vannice,may lie in the finding that Ret has a high potential for
J.L., and Collins, F. (1989). Science 246, 1023–1025.oncogenesis, and mutations of Ret are associated with
Lin, L.-F.H., Doherty, D.H., Lile, J.D., Bektesh, S., and Collins, F.multiple endocrine neoplasias. Since mere overexpres-
(1993). Science 260, 1130–1132.
sion of many receptor tyrosine kinases is sufficient for
Lindsay, R.M. (1995). Nature 373, 289–290.malignant transformation, nature may have chosen to
Moore, M.W., Klein, R.D., Farin˜as, I., Sauer, H., Armanini, M., Phillips,use nonsignaling accessory components as the abun-
H., Reichardt, L.F., Ryan, A.M., Carver-Moore, K., and Rosenthal,
dant recruiter of ligand to the cell surface, where it can A. (1996). Nature 382, 76–79.
subsequently and efficiently interact with relatively low Pichel, J.G., Shen, L., Sheng, H.Z., Granholm, A.-C., Drago, J., Grin-
(and thus safe) levels of a potentially risk-laden signal berg, A., Lee, E.J., Huang, S.P., Saarma, M., Hoffer, B.J., Sariola,
transducer. H., and Westphal, H. (1996). Nature 382, 73–76.
Conclusion Poulsen, K.T., Armanini, M.P., Klein, R.D., Hynes, M.A., Phillips, H.S.,
and Rosenthal, A. (1994). Neuron 13, 1245–1252.The GDNF example highlights the fact that variants of
the same basic protein domain can be employed to bind Sa´nchez, M.P., Silos-Santiago, I., Frise´n, J., He, B., Lira, S.A., and
Barbacid, M. (1996). Nature 382, 70–73.to totally different partners. While GDNF is most related
Schlessinger, J., Lax, I., and Lemmon, M. (1995). Cell 83, 357–360.to the TGFbs, it shares a basic cysteine knot structure
with ligands such as NGF and PDGF (Sun and Davies, Stahl, N., and Yancopoulos, G.D. (1993). Cell 74, 587–590.
1995). The extracellular domains of the various receptors Sun, P.D., and Davies, D.R. (1995). Annu. Rev. Biophys. Biomol.
Struct. 24, 269–291.bound by all these factors appear to be structurally quite
Treanor, J.J.S., Goodman, L., de Sauvage, F., Stone, D.M., Poulsen,diverse, as are their intracellular signaling domains.
K.T., Beck, C.D., Gray, C., Armanini, M.P., Pollock, R.A., Hefti, F.,Thus, it is becoming clear that it can be deceptive to
Phillips, H.S., Goddard, A., Moore, M.W., Buj-Bello, A., Davies, A.M.,predict the receptor and signaling pathways exploited
Asai, N., Takahashi, M., Vandlen, R., Henderson, C.E., and Rosen-
by a particular growth factor based simply on its struc- thal, A. (1996). Nature 382, 80–83.
ture. But those of us who wrongly assumed that GDNF
Trupp, M., Ryeden, M., Jo¨rnvall, H., Funakoshi, H., Timmusk, T.,
surely bound to a TGFb-like receptor system should not Arenas, E., and Iba´n˜ez, C.F. (1995). J. Cell Biol. 130, 137–148.
be ashamed that we were fooled by superficial appear- Trupp, M., Arenas, E., Fainzilber, M., Nilsson, A.-S., Sieber, B.-A.,
ance. After all, it has taken mammalian taxonomists hun- Grigoriou, M., Kilkenny, C., Salazar-Grueso, E., Pachnis, V., Aruma¨e,
dreds of years, and the most sophisticated of genetic U., Sariola, H., Saarma, M., Iba´n˜ez, C.F. (1996). Nature 381, 785–789.
technologies, to finally realize that the guinea pig is not,
after all, a rodent (D’Erchia et al., 1996)!
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